Purple Biotech Ltd
PPBT
$2.30
$0.0251.10%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 54.89% | 91.51% | 53.19% | 22.88% | |
| Total Depreciation and Amortization | -4.08% | -16.67% | -7.55% | 4.35% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 83.89% | 49.13% | -213.91% | -186.22% | |
| Change in Net Operating Assets | 60.66% | -195.08% | -66.40% | 46.55% | |
| Cash from Operations | 61.17% | 59.57% | 23.88% | 16.19% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 25.29% | -48.65% | -56.28% | -98.07% | |
| Cash from Investing | 22.99% | -48.65% | -56.06% | -97.52% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 15.22% | -14.29% | -9.52% | -7.14% | |
| Issuance of Common Stock | -21.45% | 109,075.00% | 16.05% | -5.32% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 55.29% | -108.87% | -10.39% | 31.46% | |
| Cash from Financing | -15.47% | -7.23% | 17.98% | 1.52% | |
| Foreign Exchange rate Adjustments | 800.00% | -100.00% | 78.26% | -104.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 70.07% | 419.19% | 26.06% | -165.72% | |